T-Compare
Evidence-style education on enclomiphene and TRT, testosterone symptoms, fertility, telehealth access, therapy costs, and how to use T-Compare comparisons without replacing medical advice.
47 articles
Full breakdown of Hims’ enclomiphene-based Testosterone Rx: how the telehealth program works, what compounded medication means, advertised pricing math (including ~$99/mo entry), and an editorial review against what actually matters-labs, eligibility, and follow-up.
Read more
Maximus Tribe runs multiple testosterone-related protocols (enclomiphene-only, oral testosterone bundles, and more). Here is how to read their public pricing, what annual billing does to the monthly number, and a pre-signup checklist grounded in first-party pages and trial citations-not forum rumors.
Read more
TTime enclomiphene is listed at the lowest public monthly anchor among T-Compare’s U.S. enclomiphene providers (~$69/mo). This overview explains what that number does and does not include, how “faster start” maps to process, and how to cross-check claims with the T·TIME interview and your clinician.
Read more
Hims vs Hone Health is a category mismatch unless you hold therapy type constant: Hims’ public flagship is enclomiphene-first Testosterone Rx; Hone historically markets a broader TRT + adjunct menu with separate membership and medication lines. Here is a numbers-first framework with Hims-sourced plan ladders and T-Compare anchors for Hone.
Read more